The use of Revolade (eltrombopag) may cause severe hepatotoxicity and potentially deadly fatal liver injury, warns Canada’s health regulator, Health Canada, according to Healthy Canadians, Government of Canada. Revolade, which is a thrombopoietin receptor agonist, is manufactured and marketed by GlaxoSmithKline under the trade name Promacta in the United States. Promacta is marketed as Revolade in the European Union.
Cases of severe drug-induced Revolade liver injury that have led to hepatotoxicity and potentially fatal liver injury have been reported in patients during clinical trials and in the post-marketing period. Patients diagnosed with severe liver impairment are advised against taking Revolade, according to Healthy Canadians. Continue reading
September 11th Victim Compensation Fund (VCF) Special Master Rupa Bhattacharyya announced at the beginning of August that the VCF is again accepting new claims using a redesigned claim form with an improved online claims system. Individuals who do not have consistent Internet access will still be able to file a hard copy claim using the new form.
The staff for the 9/11 VCF has learned from the past five years how to reduce the number of frequently asked questions and combine the four previous versions into one, simplified form. The VCF staff also solicited input from various law firms that represent VCF claimants and incorporated their feedback into the redesigned system. Continue reading
A parasite that officials believe was in at least 20 community pools has sickened more than 100 people in Maricopa County, Arizona. The parasite is passed through stool and is commonly transmitted through contaminated drinking water or recreational water facilities that have infected fecal matter present.
Cryptosporidium, or “Crypto,”is a highly contagious parasite that is difficult to get rid of because chlorine is not always effective in killing it. According to the Mayo Clinic, alcohol-based hand sanitizer isn’t effective against Crypto, so washing hands with soap and water is found to be the best prevention. Continue reading
An attempt was made by Johnson & Johnson (J&J) to overturn the largest award seen to date in a $70 million Risperdal gynecomastia verdict. The Pennsylvania judge presiding over the matter refused the request made by the manufacturer of J&J’s Janssen Pharmaceuticals division to reduce the award.
A young man began taking Risperdal in 2003 at the age of 5, to treat psychiatric problems. Risperdal was initially used to treat schizophrenia, but is also used for bipolar disorder and autism. It was not until 2013, that the man filed a lawsuit as he had developed abnormally large breasts, a condition called gynecomastia. Continue reading
For children and adults who suffer from severe allergic reactions, the cost of EpiPens have gone through the roof in the past few years. This leaves those who are in need of the life-saving device scrambling in a market that offers minimal alternatives.
The drug’s manufacturer, Mylan, is being asked by members of Congress for more information on why the cost of a two-pen set is now listed at more than $600. When Mylan took over rights to EpiPen in 2007, a pair of syringes cost $93.88. Continue reading
Ciprofloxacin is a fluroquinolone antibiotic that fights different types of bacterial infections, such as urinary tract or gastrointestinal infections. It is also used to treat people who have been exposed to anthrax. Ciprofloxacin should only be used for infections that cannot be treated with a safer antibiotic as it has been known to cause some serious or disabling side effects.
Cipro has been the subject of a class action lawsuit where a partial settlement has been reached. The lawsuit claims that Bayer Corporation, Barr Laboratories, Inc., Hoechst Marion Roussel, Inc., Watson Pharmaceuticals, Inc., and The Rugby Group, Inc. violated antitrust and consumer protections laws by cooperating to not compete with one another. They also allegedly agreed to keep lower cost generic versions of Cipro off the market. The manufacturers deny this claim. Continue reading
Biomet is facing a new lawsuit alleging that its metal-on-metal hip implant is to blame for a New York woman’s injuries. The plaintiff is a 61-year-old woman who was implanted with the Biomet M2a Magnum Hip Replacement System in her right hip six years ago. As the name implies, the implant is a metal-on-metal hip device where all contacting surfaces are made of metal. The suit alleges that the all-metal design caused the plaintiff to suffer injuries and ultimately implant failure, forcing her to undergo revision surgery to remove the implant.
The plaintiff alleges that she suffered severe and constant pain, swelling, tissue damage, synovial fluid buildup, lack of mobility and metal poisoning (metallosis). As a result of these complications, the lawsuit alleges, the plaintiff had to undergo revision surgery to remove the implant. The suit alleges that these injuries caused the plaintiff emotional distress and loss of enjoyment of her life. Continue reading
Following reports of skin irritation and burns, McDonald’s is recalling 29 million “Step It!” fitness trackers included in some Happy Meals. According to a statement from the U.S. Consumer Product Safety Commission, McDonald’s received more than 70 reports of adverse events associated with the fitness bands, including seven reports of blisters.
Last week, the fast-food giant pulled the wristbands from stores in the United States and Canada. Company spokesperson Terri Hickey told USA Today said the wristbands are no longer being offered with Happy Meals. “We have taken this swift and voluntary step after receiving limited reports of potential skin irritations that may be associated with wearing the band,” she said in a statement. Continue reading
Medical device manufacturers are required to report any event that “reasonably suggests a device may have caused or contributed to a death or serious injury.” Madris Tomes, a former FDA consultant, conducted an analysis showing that 4,000 patient deaths were labeled as “injuries” or “malfunctions” between 2011 and 2015. She says these labels are important because they help determine which issues are priorities for public health analysts.
When a death gets categorized as an “injury” or “malfunction”, it delays reviews of that issue. “The way that the FDA reviews the [safety] reports is in order of importance by the classification that is checked on the form,” Tomes said, according to NBC. “So if it is an injury or malfunction, it could take them weeks to months to get to reading them.” Continue reading
A deadly crash over the weekend leaves six people dead and another five injured on Long Island. Authorities say a speeding SUV caused the crash when it came up fast on a work zone on the Long Island Expressway. The driver of the vehicle, a Subaru Outback, reportedly swerved to avoid the slowed traffic and collided with cars on the opposite side.
Several witnesses say the Subaru was speeding before it swerved and hurdled across the grassy median, according to Suffolk police Chief of Detectives Gerard Gigante. The car became airborne and slammed into two cars, a BMW and a Honda, heading west. The crash killed the 26-year-old driver of the Subaru, along with his 27-year-old sister and 10-year-old son. Continue reading